Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1415.3061.45 (+4.54 %)
PREV CLOSE () 1353.85
OPEN PRICE () 1354.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 325323
TODAY'S LOW / HIGH ()1354.55 1418.00
52 WK LOW / HIGH ()1165.55 1672.2
NSE1415.7063.9 (+4.73 %)
PREV CLOSE() 1351.80
OPEN PRICE () 1372.00
BID PRICE (QTY) 1415.70 (61)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3368853
TODAY'S LOW / HIGH() 1370.60 1418.20
52 WK LOW / HIGH ()1165.7 1673
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1935

Management Info :

Y K Hamied - Chairman Achin Gupta - Managing Director

Registered Office :

Address : Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000 / 41916000

Website : www.cipla.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg
NEWS
16Jun Grant Of Stock Options And The Employ
Grant of Stock Options and Employee Stock Appreciation Rights (ESARs)
13May Cipla’s consolidated net profit falls
Cipla has reported results for the fourth quarter (Q4FY26) and year ende..
13May Cipla informs about investor presentat
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
13May Grant Of Stock Options And The Employ
Grant of stock options and employee stock appreciation rights (ESARs)
23Apr Cipla’s arm gets USFDA’s final nod for
Cipla’s wholly owned subsidiary -- Cipla USA Inc (Cipla) has received fi..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit3846.435151.8
Gross Profit 5224.8 46359.4
Operating Profit 7783.355890.4
Net Sales 42099.8189799.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma (BSE)
 8556.55 (1.78%)
M.Cap ( in Cr)
21391.38
Ajanta Pharma (BSE)
 3188.75 (4.12%)
M.Cap ( in Cr)
39838.85
Mankind Pharma (BSE)
 2537.05 (4.95%)
M.Cap ( in Cr)
104779.14
NGL Fine-Chem (BSE)
 3156.15 (2.67%)
M.Cap ( in Cr)
1949.88
Coral Laboratories (BSE)
 621.50 (13.11%)
M.Cap ( in Cr)
222.04
Shareholding Pattern
PROMOTERS 29.21%
MUTUAL FUNDS/UTI 18.66%
NON-INSTITUTION 16.26%
FI/BANKS/INSURANCE 11.29%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX77094.07291.17 (0.38%)
NIFTY24102.9089.80 (0.37%)
Dow Jones 51564.7072.15 (0.14%)
Nasdaq 26517.93496.27 (1.91%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI